Species in Botica Alternativa / Bifidobacterium Adolescentis

  1. bifidobacterium adolescentis

Infer Impacts Botica Alternativa / Bifidobacterium Adolescentis on Symptoms

Probiotic:
Symptom:

Not sufficient information to infer impact

Bacteria Impacts of Botica Alternativa / Bifidobacterium Adolescentis

If you find any studies of this specific probiotic impacting other bacteria, please email ken/at/lassesen.com with the URI

This table is estimated from the impact of EACH species in the probiotics reported in clinical studies. In some cases, one species will increase and another decrease. Often, all of the species have similar (or no impact).

Genus Level Only Listed
BacteriaIncrease %Decrease %
Acetanaerobacterium 100 0
Acetivibrio 100 0
Acutalibacter 100 0
Agathobaculum 100 0
Allobaculum 100 0
Anaerofilum 100 0
Anaeromassilibacillus 100 0
Anaerotruncus 100 0
Angelakisella 100 0
Bittarella (ex Durand et al. 2017) 100 0
Burkholderia 100 0
Candidatus Soleaferrea 100 0
Caproiciproducens 100 0
Collinsella 100 0
Coprococcus 100 0
Coriobacterium 100 0
Dorea 100 0
Drancourtella 100 0
Enorma 100 0
Ethanoligenens 100 0
Faecalibacterium 100 0
Flavonifractor 100 0
Fournierella 100 0
Gemmiger 100 0
Gorbachella 100 0
Harryflintia 100 0
Hydrogenoanaerobacterium 100 0
Massilimalia 100 0
Negativibacillus 100 0
Neglectibacter 100 0
Neobittarella 100 0
Odoribacter 0 100
Olegusella 100 0
Oscillospira 50 50
Papillibacter 100 0
Parvibacter 100 0
Phocea 100 0
Prevotella 100 0
Proteus 0 100
Provencibacterium 100 0
Pseudoflavonifractor 100 0
Rikenella 100 0
Ruminococcus 100 0
Ruthenibacterium 100 0
Senegalimassilia 100 0
Sporobacter 100 0
Subdoligranulum 100 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)